Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa

被引:18
|
作者
Cheng, Chih-Yuan [1 ,2 ,3 ]
Quaife, Matthew [1 ]
Eakle, Robyn [4 ]
Escobar, Maria A. Cabrera [4 ]
Vickerman, Peter [5 ]
Terris-Prestholt, Fern [1 ]
机构
[1] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England
[2] Heidelberg Univ, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany
[3] German Canc Res Ctr, Div Hlth Econ, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[4] Univ Witwatersrand, Wits RHI, 22 Esselen St, ZA-2001 Johannesburg, South Africa
[5] Univ Bristol, Sch Social & Community Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England
基金
英国经济与社会研究理事会;
关键词
HIV prevention; Long-acting injectable pre-exposure prophylaxis; Heterosexual men; South Africa; Biomedical strategies; ANTIRETROVIRAL PROPHYLAXIS; PREVENTION; INFECTION; SEX; RISK; PREFERENCES; TRANSMISSION; WILLINGNESS; PERCEPTIONS; TENOFOVIR;
D O I
10.1186/s12889-019-7276-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundHeterosexual men in South Africa are a large key population to exposure to HIV, yet preferences for HIV pre-exposure prophylaxis (PrEP) among this population have not, to date, been investigated in the literature. This paper aims to explore HIV prevention preferences among heterosexual men in urban South Africa, as well as to examine the demand and characteristics of men who favour long-acting injectable (LAI) PrEP over condoms and oral PrEP.MethodsData were collected among 178 self-reported HIV-negative heterosexual men, who were given example products and information before being asked which they preferred. Multivariate logistic regression was used to analyse which characteristics were associated with product choice.Results48% (n=85) of participants preferred LAI PrEP, while 33% (n=58) and 20% (n=35) chose oral PrEP and condoms respectively. Having children (marginal effect=0.22; 95% CI [0.01, 0.44]) or having higher risk attitude scores (marginal effect=0.03; 95% CI [0.01, 0.06]) was significantly associated with a choice of LAI PrEP, while those who had unprotected anal intercourse (marginal effect=-0.42; 95% CI [-0.57, -0.27]) and those who were concerned with protection against other sexually transmitted infections over HIV (marginal effect=-0.42; 95% CI [-0.60, -0.24]) appeared less likely to prefer LAI PrEP.ConclusionsThe results suggested a relatively high demand and theoretical acceptability for LAI PrEP among heterosexual men in urban South Africa, but there appeared to be fewer distinct predictors for the willingness to use LAI PrEP compared to studies conducted among gay and bisexual men and women. Nevertheless, the findings contribute to the mapping of the demand and determinants of heterosexual men's preferences for novel antiretroviral-based prevention in sub-Saharan Africa, and the data could aid in the differentiated design of future HIV prevention strategies using LAI PrEP in conjunction with other methods.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Interrogating the promise of long-acting HIV pre-exposure prophylaxis
    Pike, Carey
    Bekker, Linda-Gail
    TRENDS IN MOLECULAR MEDICINE, 2023, 29 (02) : 93 - 98
  • [12] Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study
    Marshall, Brandon D. L.
    Goedel, William C.
    King, Maximilian R. F.
    Singleton, Alyson
    Durham, David P.
    Chan, Philip A.
    Townsend, Jeffrey P.
    Galvani, Alison P.
    LANCET HIV, 2018, 5 (09): : E498 - E505
  • [13] Multitasking Pharmacophores Support Cabotegravir-Based Long-Acting HIV Pre-Exposure Prophylaxis (PrEP)
    Wan, Zheng
    Shi, Man
    Gong, Yanqing
    Lucci, Massimo
    Li, Jinjin
    Zhou, Jiahai
    Yang, Xiao-Liang
    Lelli, Moreno
    He, Xiao
    Mao, Jiafei
    MOLECULES, 2024, 29 (02):
  • [14] Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among US Men Who Have Sex with Men
    Greene, George J.
    Swann, Greg
    Fought, Angela J.
    Carballo-Dieguez, Alex
    Hope, Thomas J.
    Kiser, Patrick F.
    Mustanski, Brian
    D'Aquila, Richard T.
    AIDS AND BEHAVIOR, 2017, 21 (05) : 1336 - 1349
  • [15] EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP)
    Kaul, Christina M.
    Moore, Brandi E.
    Kaplan-Lewis, Emma
    Casey, Eunice
    Pitts, Robert A.
    Pirallo, Patricia Pagan
    Lim, Sahnah
    Kapadia, Farzana
    Cohen, Gabriel M.
    Khan, Maria
    Mgbako, Ofole
    PLOS ONE, 2023, 18 (09):
  • [16] Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges
    Agrahari, Vivek
    Anderson, Sharon M.
    Peet, M. Melissa
    Wong, Andrew P.
    Singh, Onkar N.
    Doncel, Gustavo F.
    Clark, Meredith R.
    EXPERT OPINION ON DRUG DELIVERY, 2022, 19 (10) : 1365 - 1380
  • [17] Long-acting HIV pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) in South Africa: cost-effective at what cost?
    Jin, E. Y.
    Ahmed, A. R.
    Bekker, L. -G.
    Ciaranello, A.
    Flanagan, C. F.
    Freedberg, K. A.
    Orrell, C.
    Reddy, K. P.
    Wallace, M.
    Neilan, A. M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26
  • [18] Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment
    Minnis, Alexandra M.
    Atujuna, Millicent
    Browne, Erica N.
    Ndwayana, Sheily
    Hartmann, Miriam
    Sindelo, Siyaxolisa
    Ngcwayi, Nangamso
    Boeri, Marco
    Mansfield, Carol
    Bekker, Linda-Gail
    Montgomery, Elizabeth T.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 (06)
  • [19] A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California
    Beltran, Raiza M.
    Hunter, Lauren A.
    Packel, Laura J.
    De Martini, Loriann
    Holloway, Ian W.
    Dong, Betty J.
    Lam, Jerika
    Mccoy, Sandra I.
    Ochoa, Ayako Miyashita
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 97 (02) : 142 - 149
  • [20] A Layer Plus Approach to Implementation Research and Collaboration for Long-Acting Injectable Pre-Exposure Prophylaxis for HIV Prevention
    Pilgrim, Nanlesta A.
    Evans, Tammeka M.
    Czarnogorski, Maggie
    HEALTH PROMOTION PRACTICE, 2022, 23 (06) : 912 - 915